US Food and Drug Administration, Safety communication on T-cell malignancies following BCMA- and CD19-directed CAR-T cell immunotherapies (January 2024)

Cited by name. No followable URL — the bibliographic record is the citation.

Authors. US Food and Drug Administration

How the Institute flags it

established 1 time

Cited on 1 page

• Immune Engineering